Rani Therapeutics Holdings, Inc. (RANI)
NGM · Common · CUSIP 753018100
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RANI and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
753018100
Market Cap
Small Cap
IPO
7/30/2021 · $11.00/share
Business: Rani Therapeutics Holdings, Inc. is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The Company has developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.

Company Contact

CEO
Talat Imran
CFO
Svai Sanford
Headquarters
2051 Ringwood Avenue, San Jose, CA 95131
Phone
408-457-3700
Investor Relations
Laurence Watts, Gilmartin IR · 619-916-7620 · laurence@gilmartinir.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »